When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BHC - Insurance Vs. Generic Pricing: The Good Bad And Ugly Of Biopharma
Bausch Health Companies Inc.
Insurance company versus big pharma - whose money is it anyway?
Humana Inc. (HUM), a $39 billion health insurance company, accuses Teva Pharmaceutical Industries (TEVA), an $8 billion company, and a few other generic drug makers, of playing ugly in the generic drugs market. In a 610-page complaint filed with a Philadelphia federal court, Humana has accused these companies of conspiring to keep the prices of over 10 dozen generics at high levels. The price collusion scheme, allegedly "spearheaded" by Teva, peaked during 3Q-2013 to 1Q-2015. This new case is a follow-up by Humana of